These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 33853571)

  • 41. Withdrawal from long-term use of zopiclone, zolpidem and temazepam may improve perceived sleep and quality of life in older adults with primary insomnia.
    Lähteenmäki R; Neuvonen PJ; Puustinen J; Vahlberg T; Partinen M; Räihä I; Kivelä SL
    Basic Clin Pharmacol Toxicol; 2019 Mar; 124(3):330-340. PubMed ID: 30295409
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Benzodiazepines revisited--will we ever learn?
    Lader M
    Addiction; 2011 Dec; 106(12):2086-109. PubMed ID: 21714826
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Eszopiclone, a nonbenzodiazepine sedative-hypnotic agent for the treatment of transient and chronic insomnia.
    Najib J
    Clin Ther; 2006 Apr; 28(4):491-516. PubMed ID: 16750462
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hypnotic Discontinuation in Chronic Insomnia.
    Hintze JP; Edinger JD
    Sleep Med Clin; 2018 Jun; 13(2):263-270. PubMed ID: 29759276
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Factors associated with long-term use of hypnotics among patients with chronic insomnia.
    Takaesu Y; Komada Y; Asaoka S; Kagimura T; Inoue Y
    PLoS One; 2014; 9(11):e113753. PubMed ID: 25409018
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Electroacupuncture for tapering off long-term benzodiazepine use: study protocol of randomized controlled trial.
    Yeung WF; Chung KF; Zhang ZJ; Chan WC; Zhang SP; Ng RM; Chan CL; Ho LM; Yu YM; Lao LX
    BMC Complement Altern Med; 2017 Mar; 17(1):183. PubMed ID: 28359309
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dependence potential of antidepressants compared to benzodiazepines.
    van Broekhoven F; Kan CC; Zitman FG
    Prog Neuropsychopharmacol Biol Psychiatry; 2002 Jun; 26(5):939-43. PubMed ID: 12369270
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Handgrip strength and balance in older adults following withdrawal from long-term use of temazepam, zopiclone or zolpidem as hypnotics.
    Nurminen J; Puustinen J; Lähteenmäki R; Vahlberg T; Lyles A; Partinen M; Räihä I; Neuvonen PJ; Kivelä SL
    BMC Geriatr; 2014 Nov; 14():121. PubMed ID: 25416480
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Eszopiclone in patients with insomnia during perimenopause and early postmenopause: a randomized controlled trial.
    Soares CN; Joffe H; Rubens R; Caron J; Roth T; Cohen L
    Obstet Gynecol; 2006 Dec; 108(6):1402-10. PubMed ID: 17138773
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Insomnia due to hypnotic abuse].
    Poluektov MG; Pchelina PV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(11. Vyp. 2):24-29. PubMed ID: 28300810
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Eszopiclone improves insomnia and depressive and anxious symptoms in perimenopausal and postmenopausal women with hot flashes: a randomized, double-blinded, placebo-controlled crossover trial.
    Joffe H; Petrillo L; Viguera A; Koukopoulos A; Silver-Heilman K; Farrell A; Yu G; Silver M; Cohen LS
    Am J Obstet Gynecol; 2010 Feb; 202(2):171.e1-171.e11. PubMed ID: 20035910
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Eszopiclone for the treatment of primary insomnia: a systematic review and meta-analysis of double-blind, randomized, placebo-controlled trials.
    Liang L; Huang Y; Xu R; Wei Y; Xiao L; Wang G
    Sleep Med; 2019 Oct; 62():6-13. PubMed ID: 31518944
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Rational use of anxiolytic/sedative drugs.
    Lader M; Petursson H
    Drugs; 1983 May; 25(5):514-28. PubMed ID: 6134609
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Can valerian improve the sleep of insomniacs after benzodiazepine withdrawal?
    Poyares DR; Guilleminault C; Ohayon MM; Tufik S
    Prog Neuropsychopharmacol Biol Psychiatry; 2002 Apr; 26(3):539-45. PubMed ID: 11999905
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Rebound insomnia. A potential hazard following withdrawal of certain benzodiazepines.
    Kales A; Scharf MB; Kales JD; Soldatos CR
    JAMA; 1979 Apr; 241(16):1692-5. PubMed ID: 430730
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Rebound insomnia and rebound anxiety: a review.
    Kales A; Soldatos CR; Bixler EO; Kales JD
    Pharmacology; 1983; 26(3):121-37. PubMed ID: 6132413
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hypnotic use for insomnia management in chronic obstructive pulmonary disease.
    Roth T
    Sleep Med; 2009 Jan; 10(1):19-25. PubMed ID: 18693067
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cost effectiveness of long-term treatment with eszopiclone for primary insomnia in adults: a decision analytical model.
    Botteman MF; Ozminkowski RJ; Wang S; Pashos CL; Schaefer K; Foley DJ
    CNS Drugs; 2007; 21(4):319-34. PubMed ID: 17381185
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The effect of eszopiclone in patients with insomnia and coexisting rheumatoid arthritis: a pilot study.
    Roth T; Price JM; Amato DA; Rubens RP; Roach JM; Schnitzer TJ
    Prim Care Companion J Clin Psychiatry; 2009; 11(6):292-301. PubMed ID: 20098520
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Newer hypnotic drugs for the short-term management of insomnia: a systematic review and economic evaluation.
    Dündar Y; Boland A; Strobl J; Dodd S; Haycox A; Bagust A; Bogg J; Dickson R; Walley T
    Health Technol Assess; 2004 Jun; 8(24):iii-x, 1-125. PubMed ID: 15193209
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.